Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy.
about
Treatment for inclusion body myositisImmunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositisImmunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositisIdiopathic Inflammatory Myopathies: Clinical Approach and ManagementTreatment of inflammatory myopathy: emerging therapies and therapeutic targetsIdiopathic inflammatory myopathiesCyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositisPancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case reportIdiopathic inflammatory myopathies.Tacrolimus in refractory polymyositis with interstitial lung disease.Cutaneous dermatomyositis: an updated review of treatment options and internal associations.Recent advances in the management of adult myositis.Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprineLaboratory evaluation of the inflammatory myopathies.Evaluation and management of polymyositis.Treatment of inflammatory myopathies.Anti Jo-1 myositis. 'Mechanic's hands' and interstitial lung diseaseClinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy.Red fist and muscle weakness with a rare complication.Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome.Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.Therapeutic approaches in myositis.Management of cutaneous dermatomyositis.Update on treatment of inclusion body myositis.Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.Update on the pharmacological treatment of adult myositis.Pharmacological management of dermatomyositis.The Diagnosis and Treatment of Antisynthetase SyndromeClinical significance of antinuclear antibodies in systemic rheumatic diseases.Quantitative 3D scintigraphy shows increased muscular uptake of pyrophosphate in idiopathic inflammatory myopathy.Polymyositis with elevated serum IgG4 levels and abundant IgG4+ plasma cell infiltration: A case report and literature review.Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.The top clinical trial opportunities in therapeutic apheresis and neurology.Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up.Use of intravenous immunoglobulin therapy for myositis: an audit in South Australian patients.Two cases of refractory polymyositis accompanied with steroid myopathy.Change in muscle volume after steroid therapy in patients with myositis assessed using cross-sectional computed tomography.
P2860
Q24186948-A2DB36AC-6E98-4EF1-B86F-A38483E8F220Q24201580-6097C1B0-005D-40DE-8C9F-396BE6811B85Q24240771-F163A2B2-00D0-460A-B85D-6424FB5D268EQ26744705-B804954F-F5B0-4132-BFEC-D43614225F2EQ26796546-076FB841-73BD-40B6-9807-7A457F42903BQ27025125-B81F7963-AC65-42F4-81D6-5BFD34297C52Q28344601-F41AD0B8-3BAD-4990-82D7-EA9A745DFC29Q33864271-EDEE39C2-E8D1-4660-B8DC-5FFE503D44DAQ33924451-C56BC080-32F0-45A3-B11C-AEA3387671FFQ34296275-CC9A8949-DF53-4BB0-B3E3-536E06E4A1A2Q34349952-20AC5B54-AE25-4481-9DB0-01099335A5F0Q34481555-3E0F8F15-2B46-4FFB-85A8-84EF753878B3Q34635470-125433D1-CBEB-42B1-8A2A-04099C9B379EQ35223951-60128F98-7B7E-4A0A-A9AF-9285B0A218A8Q36352335-C9573790-7CD4-433A-9FEE-0D377F1EF28EQ36528220-587F7170-27D0-4F06-8945-10ECFD169E41Q36777089-3333EB20-B0B5-4DD8-B341-E3AE9AA5A66DQ37372933-3F232749-1C22-4F88-88C2-9C3B7CB7C785Q37597971-4A72C058-DEB8-4164-8DBB-AEFB66F2457CQ37690885-EEF9B149-6635-4CC5-AA5A-48F3AE0D82EFQ37704799-7014EC7D-CF82-4D55-AE0E-983477F37EE9Q37848694-B445673A-F718-4786-994C-36E4E3AAD6E4Q38022271-076E265B-3C8F-4CCD-94B2-CA347253A1FFQ38093096-9BB5B94F-2EBE-460B-86DD-8BE5C8BA7108Q38221095-9FD086EA-61C6-44A8-84D9-FF50BFC0E74BQ38572045-84BB6926-3B2B-4F19-8A59-B29C37AB2281Q38813275-0EDD8830-C040-4690-889F-0D977287DB28Q39425296-8664540A-F15D-427D-BECD-BB0EF54EADDAQ40984525-BE7C1C03-3DE7-4629-B3EE-1A298D8CF216Q41156101-8BF90069-75B1-4C66-83D7-68FDEF05A470Q47100192-029EFF66-04F7-492D-806A-58F10E38B6A7Q47118114-79D37AA4-8727-4BA9-BBE4-899219C77C83Q47593445-9B8D9C38-380B-4283-9741-EC44EF5C3D53Q48894285-CDF827B4-0D26-4766-863F-23C97F1AD4BBQ50903093-8AF285A1-6874-4B93-B816-771525E72EACQ51199269-D46D0F98-9221-43F7-8039-A1A12C06D78EQ53880967-EE3E6A24-8725-459B-9400-D0316E2BE8BFQ54958272-B3EF28BF-AE1A-4E6A-80B5-80972E2D9766
P2860
Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Drug therapy of the idiopathic ...... comparison of their efficacy.
@en
type
label
Drug therapy of the idiopathic ...... comparison of their efficacy.
@en
prefLabel
Drug therapy of the idiopathic ...... comparison of their efficacy.
@en
P2093
P1476
Drug therapy of the idiopathic ...... comparison of their efficacy.
@en
P2093
Targoff IN
P304
P356
10.1016/0002-9343(93)90148-I
P407
P577
1993-04-01T00:00:00Z